leaps_companies_header

Are you a media representative (journalist, blogger, etc.) and would like more information about Leaps by Bayer? Feel free to get in touch with Christophe Kampa. Do you have any queries or comments? Please use the links to the relevant contact forms.

7. November 2019

Bayer invests USD 50 Million in eGenesis Series B financing round

Read more
17. September 2019

Bayer and Informed Data Systems Inc. to develop One Drop digital therapeutics platform for multiple therapeutic areas

Read more
8. August 2019

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Read more
17. July 2019

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer

Read more
1. July 2019

Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform

Read more
2. April 2019

Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccines

Read more
1. December 2017

Bayer wagt sich mit Leaps an die irren Fragen der Biotechnologie

Read more
14. September 2017

Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A

12. December 2016

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

Read more